• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multicenter study in Turkiye of unsuppressed viremia in people living with human immunodeficiency virus: aegean experience.土耳其关于人类免疫缺陷病毒感染者未抑制病毒血症的多中心研究:爱琴海地区经验
BMC Infect Dis. 2025 Apr 23;25(1):587. doi: 10.1186/s12879-025-10988-2.
2
Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in Beijing, China.与人类免疫缺陷病毒-1 低水平病毒血症相关的因素及其对病毒学和免疫学结果的影响:中国北京的一项回顾性队列研究。
HIV Med. 2022 Mar;23 Suppl 1:72-83. doi: 10.1111/hiv.13251.
3
Impact of Low-level Viremia on Treatment Outcomes During ART - Is it Time to Revise the Definition of Virological Failure?低水平病毒血症对抗逆转录病毒治疗期间治疗结果的影响——是时候修订病毒学失败的定义了吗?
AIDS Rev. 2018 Jan-Mar;20(1):71-72.
4
Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study.南非艾滋病治疗项目中病毒血症的病毒学抑制和临床管理:一项多中心队列研究。
PLoS Med. 2020 Feb 25;17(2):e1003037. doi: 10.1371/journal.pmed.1003037. eCollection 2020 Feb.
5
Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy.低水平病毒血症可预测接受抗逆转录病毒治疗的阿曼 HIV 感染患者的病毒学失败。
J Int Assoc Provid AIDS Care. 2020 Jan-Dec;19:2325958220979817. doi: 10.1177/2325958220979817.
6
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.成人慢性未抑制的HIV感染中的结构化治疗中断(STI)
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD006148. doi: 10.1002/14651858.CD006148.
7
Very high baseline HIV viremia impairs efficacy of non-nucleoside reverse transcriptase inhibitor-based ART: a long-term observation in treatment-naïve patients.极高的基线 HIV 病毒载量会降低基于非核苷类逆转录酶抑制剂的 ART 的疗效:一项对初治患者的长期观察。
Infect Dis Poverty. 2020 Jun 22;9(1):75. doi: 10.1186/s40249-020-00700-8.
8
Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.基于 HIV-1 前病毒 DNA 基因分型的抗病毒治疗方案选择对 HIV 感染患者的病毒学结局影响:真实世界队列研究。
AIDS Patient Care STDS. 2020 Feb;34(2):51-58. doi: 10.1089/apc.2019.0198.
9
Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis.多中心美国 PEPFAR 促进项目中接受终生抗逆转录病毒治疗的 HIV 感染妇女病毒载量未抑制的相关因素:一项横断面分析
PLoS One. 2019 Oct 24;14(10):e0219415. doi: 10.1371/journal.pone.0219415. eCollection 2019.
10
Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study.极低水平HIV病毒血症患者的特征分析:一项基于社区的研究。
J Int Assoc Provid AIDS Care. 2017 May/Jun;16(3):261-266. doi: 10.1177/2325957416680028. Epub 2016 Nov 30.

引用本文的文献

1
Factors associated with viral load non-suppression among adults with HIV in Sughd region, Tajikistan: a retrospective cohort study.塔吉克斯坦苏赫德地区成人艾滋病毒感染者病毒载量未被抑制的相关因素:一项回顾性队列研究
BMC Infect Dis. 2025 Jul 7;25(1):900. doi: 10.1186/s12879-025-11270-1.

本文引用的文献

1
Prevalence and factors associated with viral non-suppression in people living with HIV receiving antiretroviral therapy in sub-Saharan Africa: A systematic review and meta-analysis.撒哈拉以南非洲地区接受抗逆转录病毒治疗的艾滋病毒感染者病毒抑制失败的流行情况及相关因素:系统评价和荟萃分析。
Rev Med Virol. 2024 May;34(3):e2540. doi: 10.1002/rmv.2540.
2
Comparison of clinician preference and HIV-ASSIST recommendations in antiretroviral therapy decision-making: A single center experience from Turkiye.比较临床医生的偏好和 HIV-ASSIST 建议在抗逆转录病毒治疗决策中的应用:来自土耳其的单中心经验。
Int J STD AIDS. 2024 May;35(6):430-437. doi: 10.1177/09564624241229464. Epub 2024 Jan 23.
3
HIV Virologic Failure among Patients with Persistent Low-Level Viremia in Nairobi, Kenya: It Is Time to Review the >1000 Virologic Failure Threshold.肯尼亚内罗毕持续低水平病毒血症患者中的 HIV 病毒学失败:是时候重新审视>1000 的病毒学失败阈值了。
Biomed Res Int. 2023 Apr 27;2023:8961372. doi: 10.1155/2023/8961372. eCollection 2023.
4
Time to Viral Load Suppression and Its Predictors Among Adult Patients on Antiretro Viral Therapy in Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Southern Ethiopia.埃塞俄比亚南部霍萨纳市尼吉斯特·埃莱尼·穆罕默德纪念综合专科医院接受抗逆转录病毒治疗的成年患者实现病毒载量抑制的时间及其预测因素
HIV AIDS (Auckl). 2023 Apr 20;15:157-171. doi: 10.2147/HIV.S408565. eCollection 2023.
5
The Relationship of Continuity of Care, Polypharmacy and Medication Appropriateness: A Systematic Review of Observational Studies.连续性护理、多种药物治疗和药物适宜性的关系:观察性研究的系统评价。
Drugs Aging. 2023 Jun;40(6):473-497. doi: 10.1007/s40266-023-01022-8. Epub 2023 Mar 27.
6
Low-level viral loads and virological failure in the integrase strand transfer era.整合酶链转移抑制剂时代的低水平病毒载量与病毒学失败
J Antimicrob Chemother. 2023 Apr 3;78(4):1111-1116. doi: 10.1093/jac/dkad056.
7
Factors associated with post-treatment control of viral load in HIV-infected patients: a systematic review and meta-analysis.HIV感染患者病毒载量治疗后控制的相关因素:一项系统评价和荟萃分析。
Int J Infect Dis. 2023 Apr;129:216-227. doi: 10.1016/j.ijid.2023.01.025. Epub 2023 Jan 25.
8
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.抗逆转录病毒药物治疗和预防成人 HIV 感染:美国国际抗病毒学会 2022 年推荐意见。
JAMA. 2023 Jan 3;329(1):63-84. doi: 10.1001/jama.2022.22246.
9
Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort.抗逆转录病毒治疗期间低水平病毒血症和病毒学突破后的病毒学失败:来自欧洲多中心队列的结果。
Clin Infect Dis. 2023 Jan 6;76(1):25-31. doi: 10.1093/cid/ciac762.
10
An empiric tool to identify Kenyans living with HIV who will have unsuppressed viremia 18 months following treatment initiation to guide differentiated care models.一种经验性工具,用于识别肯尼亚艾滋病毒感染者,这些感染者在治疗开始后 18 个月内病毒载量仍未得到抑制,以指导差异化的护理模式。
PLoS One. 2022 Jul 19;17(7):e0271520. doi: 10.1371/journal.pone.0271520. eCollection 2022.

土耳其关于人类免疫缺陷病毒感染者未抑制病毒血症的多中心研究:爱琴海地区经验

Multicenter study in Turkiye of unsuppressed viremia in people living with human immunodeficiency virus: aegean experience.

作者信息

Akbulut Ilkay, Varol Zeynep Sedef, Akca Veysel, Serin Basak Gol, Erogul Emel, Odemiş Ilker, Senbayrak Seniha, Atalay Sabri

机构信息

Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Tepecik Training and Research Hospital, Yenisehir, Gaziler Cd No: 468, 35020 Konak, Izmir, Türkiye.

Department of Public Health, Izmir Health Directorate, Izmir, Türkiye.

出版信息

BMC Infect Dis. 2025 Apr 23;25(1):587. doi: 10.1186/s12879-025-10988-2.

DOI:10.1186/s12879-025-10988-2
PMID:40269772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12020084/
Abstract

INTRODUCTION/OBJECTIVE: This Turkish study aimed to investigate the factors that contribute to the failure of virological suppression in people with human immunodeficiency virus (HIV) receiving antiretroviral therapy (ART). The factors evaluated were sociodemographic characteristics, opportunistic infections, polypharmacy, comorbidities, and the ART regimen used. The purpose of this investigation was to obtain important insights that can be utilized to improve treatment strategies at both individual and public health levels.

METHODS

This multicenter retrospective case-control study compared data from 263 patients with suppressed viremia with 125 with unsuppressed viremia, all treated at one of three hospitals in the Aegean region of Turkiye. Sociodemographic and clinical characteristics and ART regimen details were compared between the two groups. Logistic regression analysis was used to identify the predictors of virological failure.

RESULTS

Patients with unsuppressed viremia were significantly more likely to be older, have lower educational levels, and reside in large cities. Our logistic regression analysis showed that each additional month since HIV diagnosis increased the risk of virological failure by 2%. Moreover, each 1% increase in nadir CD4 + T-cells reduced the risk of virological failure by 4%. Opportunistic infections increased the risk of virological failure by 3.25 times. Interestingly, virological failure was 6.5 times more likely in patients who did not suffer ART side effects.

CONCLUSIONS

This study identified the sociodemographic, clinical, and treatment-related factors that contribute to virological failure in people with HIV in Turkiye. This can be utilized to develop individualized treatment strategies and improve virological control and clinical outcomes.

摘要

引言/目的:这项土耳其的研究旨在调查接受抗逆转录病毒疗法(ART)的人类免疫缺陷病毒(HIV)感染者病毒学抑制失败的影响因素。评估的因素包括社会人口学特征、机会性感染、多种药物治疗、合并症以及所使用的ART方案。这项调查的目的是获得重要见解,以用于改善个体和公共卫生层面的治疗策略。

方法

这项多中心回顾性病例对照研究比较了263例病毒血症得到抑制的患者与125例病毒血症未得到抑制的患者的数据,所有患者均在土耳其爱琴海地区的三家医院之一接受治疗。比较了两组患者的社会人口学和临床特征以及ART方案细节。采用逻辑回归分析来确定病毒学失败的预测因素。

结果

病毒血症未得到抑制的患者年龄更大、教育水平更低且居住在大城市的可能性显著更高。我们的逻辑回归分析表明,自HIV诊断以来每增加一个月,病毒学失败的风险增加2%。此外,最低点CD4 + T细胞每增加1%,病毒学失败的风险降低4%。机会性感染使病毒学失败的风险增加3.25倍。有趣的是,未出现ART副作用的患者病毒学失败的可能性高6.5倍。

结论

本研究确定了导致土耳其HIV感染者病毒学失败的社会人口学、临床和治疗相关因素。这可用于制定个体化治疗策略并改善病毒学控制和临床结局。